Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 81-92

  Lo, Ming Chu ^a   Yip, Tak Chun ^b,e   Ngan, Kai Cheong ^b,e   Cheng, Wai Wai ^b   Law, Chun Key ^b   Chan, Pui Shan ^a   Chan, King Chi ^a   Wong, Chris Kong Chu ^a   Wong, Ricky Ngok Shun ^a,e   Lo, Kwok Wai ^c   Ng, Wai Tong ^d,e   Lee, Wing Mui ^d,e   Tsao, Sai Wah ^e   Kwong, Lai Wan ^e   Lung, Maria Li ^e   Mak, Nai Ki ^a,e  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CXCL8; CXCR2; MIF; Nasopharyngeal carcinoma; Tumour spheres

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; 2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE RECEPTOR CXCR2; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; PARTHENOLIDE; SMALL INTERFERING RNA;

ADULT; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CXCL8 GENE; CXCR1 GENE; CXCR2 GENE; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; FEMALE; GAPDH GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MIF GENE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR BIOPSY;

HUMAN HERPESVIRUS 4;

EID: 84878462367     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.052     Document Type: Article

References (48)

1. Hildesheim A., Wang C.P. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin. Cancer Biol. 2012, 22:107-116.
2. Bei J.X., Li Y., Jia W.H., Feng B.J., Zhou G., Chen L.Z., Feng Q.S., Low H.Q., Zhang H., He F., Tai E.S., Kang T., Liu E.T., Liu J., Zeng Y.X. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet. 2010, 42:599-603.
3. Liao B., Zhong B.L., Li Z., Tian X.Y., Li Y., Li B. Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. J. Surg. Oncol. 2010, 102:844-851.
4. Lu X., Qian C.N., Mu Y.G., Li N.W., Li S., Zhang H.B., Li S.W., Wang F.L., Guo X., Xiang Y.Q. Serum CCL2 and serum TNF-alpha-two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma. Eur. J. Cancer 2011, 47:339-346.
5. Luo H.N., Li X.P., Liu X., Zhang G.H., Liu Y.L. Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 2009, 31:260-264.
6. Chang K.P., Hao S.P., Chang J.H., Wu C.C., Tsang N.M., Lee Y.S., Hsu C.L., Ueng S.H., Liu S.C., Liu Y.L., Wei P.C., Liang Y., Chang Y.S., Yu J.S. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin. Cancer Res. 2008, 14:6979-6987.
7. Hinohara K., Kobayashi S., Kanauchi H., Shimizu S., Nishioka K., Tsuji E., Tada K., Umezawa K., Mori M., Ogawa T., Inoue J., Tojo A., Gotoh N. ErbB receptor tyrosine kinase/NF-kappaB signaling controls mammosphere formation in human breast cancer. Proc. Natl. Acad. Sci. USA 2012, 109:6584-6589.
8. Hoth J.J., Wells J.D., Hiltbold E.M., McCall C.E., Yoza B.K. Mechanism of neutrophil recruitment to the lung after pulmonary contusion. Shock 2011, 35:604-609.
9. Narimatsu R., Wolday D., Patterson B.K. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res. Hum. Retroviruses 2005, 21:228-233.
10. F. Böhrnsen, U. Lindner, M. Meier, A. Gadallah, P. Schlenke, H. Lehnert, J. Rohwedel, J. Kramer. Murine mesenchymal progenitor cells from different tissues differentiated via mesenchymal microspheres into the mesodermal direction. BMC Cell Biol. 10 (2009).htt://dx.doi.org/10.1186/1471-2121-10-92.
11. Golestaneh A.F., Atashi A., Langroudi L., Shafiee A., Ghaemi N., Soleimani M. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. Cell Biochem. Funct. 2012, 30:411-418.
12. Friedrich J., Seidel C., Ebner R., Kunz-Schughart L.A. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. 2009, 4:309-324.
13. Horikawa T., Yoshizaki T., Kondo S., Furukawa M., Kaizaki Y., Pagano J.S. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br. J. Cancer 2011, 104:1160-1167.
14. Hwang W.L., Yang M.H., Tsai M.L., Lan H.Y., Su S.H., Chang S.C., Teng H.W., Yang S.H., Lan Y.T., Chiou S.H., Wang H.W. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011, 141:279-291.
15. Ren Q., Sato H., Murono S., Furukawa M., Yoshizaki T. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Laryngoscope 2004, 114:855-859.
16. Parrondo R., de las P.A., Reiner T., Rai P., Perez-Stable C. NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells. Mol. Cancer 2010, 9. 10.1186/1476-4598-9-182.
17. Yeo A.T., Porco J.A., Gilmore T.D. Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Lett. 2012, 318:53-60.
18. Sahler J., Bernard J.J., Spinelli S.L., Blumberg N., Phipps R.P. The feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-kappaB inhibition. Thromb. Res. 2011, 127:426-434.
19. Maheshwari A., Lacson A., Lu W., Fox S.E., Barleycorn A.A., Christensen R.D., Calhoun D.A. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr. Res. 2004, 56:240-249.
20. Tseng-Rogenski S., Liebert M. Interleukin-8 is essential for normal urothelial cell survival. Am. J. Physiol. Renal Physiol. 2009, 297:F816-F821.
21. Hirsch J., Johnson C.L., Nelius T., Kennedy R., Riese W., Filleur S. PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFkappaB and PPARgamma. Cytokine 2011, 55:202-210.
22. Araki S., Omori Y., Lyn D., Singh R.K., Meinbach D.M., Sandman Y., Lokeshwar V.B., Lokeshwar B.L. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res. 2007, 67:6854-6862.
23. Gabellini C., Trisciuoglio D., Desideri M., Candiloro A., Ragazzoni Y., Orlandi A., Zupi G., Del Bufalo D. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur. J. Cancer 2009, 45:2618-2627.
24. Ginestier C., Liu S., Diebel M.E., Korkaya H., Luo M., Brown M., Wicinski J., Cabaud O., Charafe-Jauffret E., Birnbaum D., Guan J.L., Dontu G., Wicha M.S. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 2010, 120:485-497.
25. Chang K.P., Chang Y.T., Wu C.C., Liu Y.L., Chen M.C., Tsang N.M., Hsu C.L., Chang Y.S., Yu J.S. Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival. Head Neck 2011, 33:886-897.
26. Ben Nasr H., Chahed K., Mestiri S., Bouaouina N., Snoussi K., Chouchane L. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum. Immunol. 2007, 68:761-769.
27. Tai S.H., Wei Y.S., Wang P., Zhou B., Ran P., Yang Z.H., Zhang L. Genetic polymorphisms of interferon-gamma and interleukin-8 in patients with nasopharyngeal carcinoma. Sichuan. Da. Xue. Xue. Bao. Yi. Xue. Ban. 2007, 38:862-865.
28. Wei Y.S., Lan Y., Tang R.G., Xu Q.Q., Huang Y., Nong H.B., Huang W.T. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin. Immunol. 2007, 125:309-317.
29. Li X.J., Peng L.X., Shao J.Y., Lu W.H., Zhang J.X., Chen S., Chen Z.Y., Xiang Y.Q., Bao Y.N., Zheng F.J., Zeng M.S., Kang T.B., Zeng Y.X., Teh B.T., Qian C.N. As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling. Carcinogenesis 2012, 33:1302-1309.
30. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., Kwong D.L., Tsao S.W., Jin D.Y. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 2008, 205:2551-2560.
31. Frappier L. Role of EBNA1 in NPC tumourigenesis. Semin. Cancer Biol. 2012, 22:154-161.
32. Kong Q.L., Hu L.J., Cao J.Y., Huang Y.J., Xu L.H., Liang Y., Xiong D., Guan S., Guo B.H., Mai H.Q., Chen Q.Y., Zhang X., Li M.Z., Shao J.Y., Qian C.N., Xia Y.F., Song L.B., Zeng Y.X., Zeng M.S. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010, 6:e1000940.
33. O'Neil J.D., Owen T.J., Wood V.H., Date K.L., Valentine R., Chukwuma M.B., Arrand J.R., Dawson C.W., Young L.S. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J. Gen. Virol. 2008, 89:2833-2842.
34. Yip W.K., Leong V.C., Abdullah M.A., Yusoff S., Seow H.F. Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncol. Rep. 2008, 19:319-328.
35. Yip W.K., Seow H.F. Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and beta-catenin and enhances invasion in nasopharyngeal carcinoma cells. Cancer Lett. 2012, 318:162-172.
36. Lau P.C., Wong E.Y. Targeting MET by tyrosine kinase inhibitor suppresses growth and invasion of nasopharyngeal carcinoma cell lines. Pathol. Oncol. Res. 2012, 18:357-363.
37. Nasser M.W., Raghuwanshi S.K., Grant D.J., Jala V.R., Rajarathnam K., Richardson R.M. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. J. Immunol. 2009, 183:3425-3432.
38. Wolff M., Kredel S., Haasen D., Wiedenmann J., Nienhaus G.U., Kistler B., Oswald F., Heilker R. High content screening of CXCR2-dependent signalling pathways. Comb. Chem. High Throughput Screen. 2010, 13:3-15.
39. Chakrabarti S., Patel K.D. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J. Leukoc. Biol. 2005, 78:279-288.
40. Matsuo Y., Campbell P.M., Brekken R.A., Sung B., Ouellette M.M., Fleming J.B., Aggarwal B.B., Der C.J., Guha S. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways. Mol. Cancer Res. 2009, 7:799-808.
41. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14:6735-6741.
42. Horikawa T., Kaizaki Y., Kato H., Furukawa M., Yoshizaki T. Expression of interleukin-8 receptor A predicts poor outcome in patients with nasopharyngeal carcinoma. Laryngoscope 2005, 115:62-67.
43. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128:2038-2049.
44. Cheng R.J., Deng W.G., Niu C.B., Li Y.Y., Fu Y. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma. Int. J. Gynecol. Cancer 2011, 21:1004-1012.
45. Fang W., Li X., Jiang Q., Liu Z., Yang H., Wang S., Xie S., Liu Q., Liu T., Huang J., Xie W., Li Z., Zhao Y., Wang E., Marincola F.M., Yao K. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J. Transl. Med. 2008, 6:32.
46. Ohta S., Misawa A., Fukaya R., Inoue S., Kanemura Y., Okano H., Kawakami Y., Toda M. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. J. Cell Sci. 2012, 125:3210-3220.
47. Du W., Wright B.M., Li X., Finke J., Rini B.I., Zhou M., He H., Lal P., Welford S.M. Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma. Oncogene 2012, 10.1038/onc.2012.143.
48. Zhang B., Shen M., Xu M., Liu L.L., Luo Y., Xu D.Q., Wang Y.X., Liu M.L., Liu Y., Dong H.Y., Zhao P.T., Li Z.C. Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension. Mediators Inflamm. 2012, 2012. 10.1155/2012/840737.